DelfaGLP-1 Atlas

Lead sponsor

Peking Union Medical College Hospital

4 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

4

Trials led

1

Active

596

Total enrollment

1

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Early Phase 1
2
Phase 4
2

Trials by status

Not yet recruiting
1
Unknown
3

Trials led

RECAP-GLP1—Ph 4Not yet recruiting396
68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis—Early Ph 1Unknown100
Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS PatientsBMI ≥25Ph 4Unknown80
[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients—Early Ph 1Unknown20